Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Breast Cancer

Free Subscription Articles published in Oncology Retrieve available abstracts of 15 articles: HTML format

Single Articles

August 2025
1. BASTA A, Lien K, Sun W, Whiting J, et al
   A real-world single-center cohort study on the tolerability of trastuzumab deruxtecan for HER2+ metastatic breast cancer.
   Oncology. 2025 Aug 4:1-18. doi: 10.1159/000547685.
   PubMed     Abstract available
   
   
   February 2025
2. NISHIMURA R, Sudo K, Kitadai R, Kawachi A, et al
   Treatment and reasons for choosing treatment in breast cancer patients who underwent next-generation sequencing test.
   Oncology. 2025 Feb 4:1-21. doi: 10.1159/000543732.
   PubMed     Abstract available
   
   
   
3. DING Y, Wu W, Ni X, Wang Z, et al
   Long-term survival of node-positive breast cancer with complete nodal response to neoadjuvant chemotherapy treated with sentinel lymph node biopsy alone: A meta-analysis.
   Oncology. 2025 Feb 3:1-23. doi: 10.1159/000543662.
   PubMed     Abstract available
   
   
   January 2025
4. JU S, Jung YJ, Lee S, Kang SK, et al
   Effects of chemotherapy( Anthracyclin, Cyclophosphamide following docetaxel regimen) on sleep, anxiety, depression and quality of life in patients with breast cancer.
   Oncology. 2025 Jan 30:1-23. doi: 10.1159/000543730.
   PubMed     Abstract available
   
   
   
5. DAWOOD S, Sandhir N, Akasheh M, El Khoury M, et al
   Genomic Landscape of Advanced Solid Tumors in Middle East and North Africa Using Circulating Tumor DNA in Routine Clinical Practice.
   Oncology. 2025;103:508-520.
   PubMed     Abstract available
   
   
   December 2024
6. GO M, Kimura M, Yamada S, Kamei K, et al
   Alternative palbociclib dosing schedules for hormone receptor-positive and HER2-negative metastatic breast cancer.
   Oncology. 2024 Dec 11:1-22. doi: 10.1159/000542991.
   PubMed     Abstract available
   
   
   November 2024
7. KARHAN O, Ileri S, Urakci Z, Arvas H, et al
   Concomitant Use of Proton Pump Inhibitors and CDK4/6 inhibitors in Metastatic Hormone-Positive Breast Cancer: A Real World Cohort Study.
   Oncology. 2024 Nov 25:1-15. doi: 10.1159/000542693.
   PubMed     Abstract available
   
   
   
8. CHIANG CH, Xu X, Shahid A, Song J, et al
   The association between body mass index and mortality in breast cancer patients receiving pembrolizumab.
   Oncology. 2024 Nov 12:1-9. doi: 10.1159/000542542.
   PubMed     Abstract available
   
   
   October 2024
9. ZHANG H, Zhang A, Wei T, Huang H, et al
   Long-term Survival Outcomes in Locally Advanced Breast Cancer after Mastectomy with or without Breast Reconstruction.
   Oncology. 2024 Oct 22:1-22. doi: 10.1159/000541771.
   PubMed     Abstract available
   
   
   September 2024
10. JUNG YJ, Lee S, Kang SK, Kim JY, et al
    Clinicopathological factors predicting pathological complete response to neoadjuvant anti-HER2 therapy in HER2-positive breast cancer.
    Oncology. 2024 Sep 9:1-16. doi: 10.1159/000541019.
    PubMed     Abstract available
    
    
    August 2024
11. OYAMA Y, Kittaka N, Higuchi A, Togashi Y, et al
    Long-term Survival Outcomes and Risk Factors for Axillary and Locoregional Recurrence in Japanese Patients with Sentinel Node-positive Breast Cancer Treated in Accordance with the ACOSOG Z0011 Strategy.
    Oncology. 2024 Aug 19. doi: 10.1159/000540363.
    PubMed     Abstract available
    
    
    
12. ZAVESKY L, Jandakova E, Weinberger V, Minar L, et al
    The overexpressed microRNAs miRs-182, 155, 493, 454 and U6 snRNA, and underexpressed let-7c, miR-328 and miR-451a as potential biomarkers in invasive breast cancer and their clinicopathological significance.
    Oncology. 2024 Aug 12. doi: 10.1159/000540863.
    PubMed     Abstract available
    
    
    July 2024
13. KOVACOVA M, Hlavac V, Kozevnikovova R, Raus K, et al
    Artificial Intelligence-driven Prediction Revealed CFTR Associated With Therapy Outcome Of Breast Cancer: A Feasibility Study.
    Oncology. 2024 Jul 18. doi: 10.1159/000540395.
    PubMed     Abstract available
    
    
    February 2024
14. ZAVESKY L, Jandakova E, Weinberger V, Minar L, et al
    Human endogenous retroviruses (HERVs) in breast cancer: altered expression pattern implicates divergent roles in carcinogenesis.
    Oncology. 2024 Feb 26. doi: 10.1159/000538021.
    PubMed     Abstract available
    
    
    January 2024
15. JEON C, Kang SH, Kim SB, Paik NS, et al
    Safety and Effectiveness of Trastuzumab Biosimilar SB3 in Korean Patients, a Post-Marketing Surveillance Study.
    Oncology. 2024;102:465-475.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.